Retinoblastoma protein expression predicts response to bacillus Calmette-Guérin immunotherapy in patients with T1G3 bladder cancer

This publication has 13 references indexed in Scilit:

• Optimal Management of the T1G3 Bladder Cancer
  Urologic Clinics of North America, 2005
• Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stress
  Cell Research, 2005
• Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
  British Journal of Cancer, 2004
• Combined Effects of p53, p21, and pRb Expression in the Progression of Bladder Transitional Cell Carcinoma
  Journal of Clinical Oncology, 2004
• p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder Cancer
  Journal of Clinical Oncology, 2004
• Do Prognostic Parameters of Remission versus Relapse after Bacillus Calmette–Guérin (BCG) Immunotherapy Exist? Analysis of a Quarter Century of Literature
  European Urology, 2003
• DOES EARLY CYSTECTOMY IMPROVE THE SURVIVAL OF PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER TUMORS?
  Journal of Urology, 2001
• Low-Dose BCG Instillations in the Treatment of Stage T1 Grade 3 Bladder Tumours: Recurrence, Progression and Success
  European Urology, 1998
• Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer
  JNCI: Journal of the National Cancer Institute, 1992
• The Role of Radical Cystectomy in the Management of High Grade Superficial Bladder Cancer (PA, P1PIS and P2)
  Journal of Urology, 1990